Search - tctmd.com

Displaying 21 - 40 of 83

Sort: Relevancy | Date

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Conference News EuroPCR 2023

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

Shelley Wood

May 16, 2023

Presentation EuroPCR 2022

The ROLEX Study(Revascularization Of LEft main with resolute onyX): A prospective, international, multicenter study of left main PCI with a zotarolimus-eluting stent

Presenter: Giuseppe Tarantini

May 31, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Conference News EuroPCR 2022

Fibromuscular Dysplasia in SCAD Tied to Worse Long-term Prognosis

Caitlin E. Cox

May 19, 2022

News Conference News EuroPCR 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Michael O'Riordan

May 18, 2022

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

L.A. McKeown

May 19, 2021

News Conference News EuroPCR 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Michael O'Riordan

May 18, 2021

News Conference News EuroPCR 2020

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Todd Neale

June 30, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News EuroPCR 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Caitlin E. Cox

June 26, 2020

News Conference News EuroPCR 2019

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

L.A. McKeown

June 07, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

News Conference News EuroPCR 2019

ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety

L.A. McKeown

May 31, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Caitlin E. Cox

May 23, 2019

News Conference News EuroPCR 2019

New Expert Advice on Intracoronary Imaging Urges Shift to Preprocedural Planning

Shelley Wood

May 22, 2019

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

Advertisement

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

The ROLEX Study(Revascularization Of LEft main with resolute onyX): A prospective, international, multicenter study of left main PCI with a zotarolimus-eluting stent

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Fibromuscular Dysplasia in SCAD Tied to Worse Long-term Prognosis

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

Elective Revascularization, Better Long-term Survival: Meta-analysis

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

New Expert Advice on Intracoronary Imaging Urges Shift to Preprocedural Planning

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content